Sunanda Chatterjee

844 total citations
7 papers, 667 citations indexed

About

Sunanda Chatterjee is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Sunanda Chatterjee has authored 7 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Sunanda Chatterjee's work include Cancer-related Molecular Pathways (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Epigenetics and DNA Methylation (2 papers). Sunanda Chatterjee is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Epigenetics and DNA Methylation (2 papers). Sunanda Chatterjee collaborates with scholars based in United States, India and Germany. Sunanda Chatterjee's co-authors include Richard J. Côté, Susan Groshen, Donald G. Skinner, John P. Stein, Peter A. Jones, Ram H. Datar, Clive R. Taylor, Peter J. Goebell, Ben George and David Esrig and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and The Journal of Urology.

In The Last Decade

Sunanda Chatterjee

7 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sunanda Chatterjee United States 6 417 317 244 231 123 7 667
Ben George United States 6 294 0.7× 220 0.7× 117 0.5× 131 0.6× 89 0.7× 13 473
Changyi Quan China 11 138 0.3× 438 1.4× 96 0.4× 152 0.7× 124 1.0× 32 592
T. S. Tzai Taiwan 7 153 0.4× 142 0.4× 143 0.6× 74 0.3× 33 0.3× 14 381
Howard B. Heidenberg United States 7 44 0.1× 282 0.9× 165 0.7× 411 1.8× 154 1.3× 8 594
Christine G. Hammerschmied Germany 8 85 0.2× 287 0.9× 126 0.5× 125 0.5× 120 1.0× 10 436
Tumi Toro New Zealand 8 404 1.0× 667 2.1× 211 0.9× 151 0.7× 120 1.0× 11 1.0k
Satoshi Taga Japan 10 56 0.1× 217 0.7× 191 0.8× 251 1.1× 113 0.9× 18 514
B Torsello Italy 11 119 0.3× 350 1.1× 69 0.3× 281 1.2× 177 1.4× 19 612
Asha Padar United States 8 69 0.2× 561 1.8× 119 0.5× 115 0.5× 119 1.0× 8 665
Yasuhiro Komuro Japan 10 235 0.6× 144 0.5× 348 1.4× 110 0.5× 50 0.4× 17 497

Countries citing papers authored by Sunanda Chatterjee

Since Specialization
Citations

This map shows the geographic impact of Sunanda Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunanda Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunanda Chatterjee more than expected).

Fields of papers citing papers by Sunanda Chatterjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunanda Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunanda Chatterjee. The network helps show where Sunanda Chatterjee may publish in the future.

Co-authorship network of co-authors of Sunanda Chatterjee

This figure shows the co-authorship network connecting the top 25 collaborators of Sunanda Chatterjee. A scholar is included among the top collaborators of Sunanda Chatterjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunanda Chatterjee. Sunanda Chatterjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Satpati, Priyadarshi, et al.. (2024). De Novo Design of Tryptophan Containing Broad‐Spectrum Cationic Antimicrobial Octapeptides. ChemMedChem. 20(2). e202400566–e202400566. 2 indexed citations
2.
Shi, Yan, Sunanda Chatterjee, F. Brands, et al.. (2005). Role of coordinated molecular alterations in the development of androgen‐independent prostate cancer: an in vitro model that corroborates clinical observations. British Journal of Urology. 97(1). 170–178. 22 indexed citations
3.
Chatterjee, Sunanda, Ben George, Peter J. Goebell, et al.. (2004). Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer. The Journal of Pathology. 203(3). 762–770. 67 indexed citations
4.
Chatterjee, Sunanda, Ram H. Datar, Ben George, et al.. (2004). Combined Effects of p53, p21, and pRb Expression in the Progression of Bladder Transitional Cell Carcinoma. Journal of Clinical Oncology. 22(6). 1007–1013. 196 indexed citations
5.
Shi, Yan, F. Brands, Sunanda Chatterjee, et al.. (2001). HER-2/NEU EXPRESSION IN PROSTATE CANCER: HIGH LEVEL OF EXPRESSION ASSOCIATED WITH EXPOSURE TO HORMONE THERAPY AND ANDROGEN INDEPENDENT DISEASE. The Journal of Urology. 166(4). 1514–1519. 100 indexed citations
6.
Côté, Richard J. & Sunanda Chatterjee. (1999). Molecular determinants of outcome in bladder cancer.. PubMed. 5(1). 2–15. 35 indexed citations
7.
Stein, John P., David A. Ginsberg, Gary D. Grossfeld, et al.. (1998). Effect of p21WAF1/CIP1 Expression on Tumor Progression in Bladder Cancer. JNCI Journal of the National Cancer Institute. 90(14). 1072–1079. 245 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026